Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Alopecia Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Oral treatment
  • 1.3.3 Topical treatment
  • 1.3.4 Other treatment
• 1.4 Market Segment by Application
  • 1.4.1 Global Alopecia Market Share by Application (2019-2025)
  • 1.4.2 Male
  • 1.4.3 Female
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Alopecia Market Size
  • 2.1.1 Global Alopecia Revenue 2014-2025
  • 2.1.2 Global Alopecia Sales 2014-2025
• 2.2 Alopecia Growth Rate by Regions
  • 2.2.1 Global Alopecia Sales by Regions 2014-2019
  • 2.2.2 Global Alopecia Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Alopecia Sales by Manufacturers
  • 3.1.1 Alopecia Sales by Manufacturers 2014-2019
  • 3.1.2 Alopecia Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Alopecia Revenue by Manufacturers (2014-2019)
  • 3.2.2 Alopecia Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Alopecia Market Concentration Ratio (CR5 and HHI)
• 3.3 Alopecia Price by Manufacturers
• 3.4 Key Manufacturers Alopecia Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Alopecia Market
• 3.6 Key Manufacturers Alopecia Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Oral treatment Sales and Revenue (2014-2019)
  • 4.1.2 Topical treatment Sales and Revenue (2014-2019)
  • 4.1.3 Other treatment Sales and Revenue (2014-2019)
• 4.2 Global Alopecia Sales Market Share by Type
• 4.3 Global Alopecia Revenue Market Share by Type
• 4.4 Alopecia Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Alopecia Sales by Application

6 United States

• 6.1 United States Alopecia Breakdown Data by Company
• 6.2 United States Alopecia Breakdown Data by Type
• 6.3 United States Alopecia Breakdown Data by Application

7 European Union

• 7.1 European Union Alopecia Breakdown Data by Company
• 7.2 European Union Alopecia Breakdown Data by Type
• 7.3 European Union Alopecia Breakdown Data by Application

8 China

• 8.1 China Alopecia Breakdown Data by Company
• 8.2 China Alopecia Breakdown Data by Type
• 8.3 China Alopecia Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Alopecia Breakdown Data by Company
• 9.2 Rest of World Alopecia Breakdown Data by Type
• 9.3 Rest of World Alopecia Breakdown Data by Application
• 9.4 Rest of World Alopecia Breakdown Data by Countries
  • 9.4.1 Rest of World Alopecia Sales by Countries
  • 9.4.2 Rest of World Alopecia Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Lifes2good
  • 10.1.1 Lifes2good Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Alopecia
  • 10.1.4 Alopecia Product Introduction
  • 10.1.5 Lifes2good Recent Development
• 10.2 Kirkland Signature
  • 10.2.1 Kirkland Signature Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Alopecia
  • 10.2.4 Alopecia Product Introduction
  • 10.2.5 Kirkland Signature Recent Development
• 10.3 Johnson & Johnson
  • 10.3.1 Johnson & Johnson Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Alopecia
  • 10.3.4 Alopecia Product Introduction
  • 10.3.5 Johnson & Johnson Recent Development
• 10.4 Dr. Reddy’s Laboratories.
  • 10.4.1 Dr. Reddy’s Laboratories. Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Alopecia
  • 10.4.4 Alopecia Product Introduction
  • 10.4.5 Dr. Reddy’s Laboratories. Recent Development
• 10.5 Cipla.
  • 10.5.1 Cipla. Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Alopecia
  • 10.5.4 Alopecia Product Introduction
  • 10.5.5 Cipla. Recent Development
• 10.6 Alpecin.
  • 10.6.1 Alpecin. Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Alopecia
  • 10.6.4 Alopecia Product Introduction
  • 10.6.5 Alpecin. Recent Development
• 10.7 Vitabiotics.
  • 10.7.1 Vitabiotics. Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Alopecia
  • 10.7.4 Alopecia Product Introduction
  • 10.7.5 Vitabiotics. Recent Development
• 10.8 Sun Pharma.
  • 10.8.1 Sun Pharma. Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Alopecia
  • 10.8.4 Alopecia Product Introduction
  • 10.8.5 Sun Pharma. Recent Development
• 10.9 Phyto Ales Group
  • 10.9.1 Phyto Ales Group Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Alopecia
  • 10.9.4 Alopecia Product Introduction
  • 10.9.5 Phyto Ales Group Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Alopecia Sales Channels
  • 11.2.2 Alopecia Distributors
• 11.3 Alopecia Customers

12 Market Forecast

• 12.1 Global Alopecia Sales and Revenue Forecast 2019-2025
• 12.2 Global Alopecia Sales Forecast by Type
• 12.3 Global Alopecia Sales Forecast by Application
• 12.4 Alopecia Forecast by Regions
  • 12.4.1 Global Alopecia Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Alopecia Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues.
Asia Pacific is expected to grow at a lucrative CAGR of 5.3% over the coming eight years. The large population suffering from alopecia and the rising awareness levels pertaining to the available therapeutic options is one of the key factors for the region's high growth rate. The economic development coupled with the constantly rising disposable income in countries such as China, India, and Singapore will present high growth opportunities. The recent innovations and technological trends in alopecia treatment, the increasing healthcare expenditures, and the augmented healthcare facilities are expected to boost the alopecia treatment market.
In 2019, the market size of Alopecia is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alopecia.

This report studies the global market size of Alopecia, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Alopecia sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Lifes2good
Kirkland Signature
Johnson & Johnson
Dr. Reddy’s Laboratories.
Cipla.
Alpecin.
Vitabiotics.
Sun Pharma.
Phyto Ales Group

Market Segment by Product Type
Oral treatment
Topical treatment
Other treatment

Market Segment by Application
Male
Female

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Alopecia status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Alopecia manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Alopecia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025